Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IBTD
3026
DELISTED
iShares iBonds Dec 2023 Term Treasury ETF
IBTD
| $9.47M | ﹤0.01% |
382,180
+382,080
| +382,080% | +$9.5M |
|
3027
State Street SPDR S&P Transportation ETF
XTN
$395M
| $9.46M | ﹤0.01% |
148,788
-36,320
| -20% | -$2.65M |
|
|
HA
3028
DELISTED
Hawaiian Holdings, Inc.
HA
| $9.42M | ﹤0.01% |
716,691
+42,675
| +6% | +$651K |
|
3029
Enanta Pharmaceuticals
ENTA
$383M
| $9.42M | ﹤0.01% |
181,674
-63,200
| -26% | -$3.69M |
|
3030
NewMarket
NEU
$8.85B
| $9.42M | ﹤0.01% |
31,317
+6,469
| +26% | +$1.94M |
|
3031
Pathward Financial
CASH
$1.8B
| $9.4M | ﹤0.01% |
285,309
-27,341
| -9% | -$982K |
|
3032
ALPS International Sector Dividend Dogs ETF
IDOG
$568M
| $9.39M | ﹤0.01% |
440,428
-559
| -0.1% | -$13.6K |
|
3033
First Trust SSI Strategic Convertible Securities ETF
FCVT
$104M
| $9.38M | ﹤0.01% |
301,246
+63,279
| +27% | +$2.09M |
|
3034
Global Net Lease
GNL
$1.85B
| $9.38M | ﹤0.01% |
880,234
-115,539
| -12% | -$1.61M |
|
3035
Kratos Defense & Security Solutions
KTOS
$12.1B
| $9.36M | ﹤0.01% |
921,599
-49,655
| -5% | -$665K |
|
3036
FlexShares iBoxx 5-Year Target Duration TIPS Index Fund
TDTF
$1.04B
| $9.36M | ﹤0.01% |
399,909
-71,921
| -15% | -$1.81M |
|
3037
Verra Mobility
VRRM
$717M
| $9.34M | ﹤0.01% |
607,907
+42,478
| +8% | +$689K |
|
3038
Prospect Capital
PSEC
$1.15B
| $9.34M | ﹤0.01% |
1,506,152
+104,732
| +7% | +$782K |
|
3039
Upwork
UPWK
$1.06B
| $9.32M | ﹤0.01% |
684,421
-907,066
| -57% | -$17.1M |
|
3040
Avantis Emerging Markets Equity ETF
AVEM
$26.9B
| $9.31M | ﹤0.01% |
202,699
+20,440
| +11% | +$1.04M |
|
3041
Franklin FTSE Japan ETF
FLJP
$4.14B
| $9.3M | ﹤0.01% |
428,944
+64,700
| +18% | +$1.53M |
|
3042
MarineMax
HZO
$1.15B
| $9.3M | ﹤0.01% |
312,144
-42,160
| -12% | -$1.58M |
|
|
ZY
3043
DELISTED
Zymergen Inc. Common Stock
ZY
| $9.3M | ﹤0.01% |
3,344,467
+1,184,659
| +55% | +$2.88M |
|
|
DMC
3044
Del Monte Corp
DMC
$1.43B
| $9.28M | ﹤0.01% |
399,343
+119,436
| +43% | +$3.33M |
|
|
FPAC
3045
DELISTED
Far Peak Acquisition Corporation
FPAC
| $9.26M | ﹤0.01% |
936,013
-12,300
| -1% | -$121K |
|
|
B
3046
DELISTED
Barnes Group Inc.
B
| $9.26M | ﹤0.01% |
320,472
-127,337
| -28% | -$4.08M |
|
3047
iShares MSCI Italy ETF
EWI
$1.08B
| $9.25M | ﹤0.01% |
430,391
+9,635
| +2% | +$227K |
|
3048
PennyMac Financial
PFSI
$4.05B
| $9.25M | ﹤0.01% |
215,619
+46,984
| +28% | +$2.46M |
|
3049
United Parks & Resorts
PRKS
$2.04B
| $9.24M | ﹤0.01% |
203,086
+4,108
| +2% | +$204K |
|
3050
Arcus Biosciences
RCUS
$3.75B
| $9.24M | ﹤0.01% |
353,061
-230,635
| -40% | -$6.1M |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.